Search Tag: Merck
2021 04 Nov
U.K.’s Medicines and Healthcare Products Regulatory Agency has authorised the first oral antiviral medicine for treating mild-to-moderate COVID-19 in adults with a positive COVID-19 infection and at least one risk factor for developing severe illness. Molnupiravir will be the first oral medicine authorised for COVID-19. This is a major achievement...Read more